Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Go back to Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program
(NASDAQ: QNRX) Delayed: 4.65 +0.03 (0.65%)
Previous Close $4.62    52 Week High
Open $4.63    52 Week Low
Day High $4.68    P/E N/A 
Day Low $4.50    EPS
Volume 6,556